Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia

Inclusion Criteria: * Age: 25yrs\~75yrs * Fasting TG \<400mg/dL, LDL-C ≥130mg/dL * 3months \> Diagnosed Type2 DM, With OAD, HbA1c ≤ 10.0% or First Diagnosed Type2 DM, 6.5%≤HbA1c≤10.0% Exclusion Criteria: * Type1 DM, Gestational diabetes * Patient need to treat with Insulin * Patient with operational treatment for severe diabetic complication * Uncontrolled Hypothyroidism * Unstable angina, MI, transient ischemic attack(TIA), Stroke, PCI, Heart Failure within 3 months (NYHA class4) * Severe Hypertension (SBP ≥ 180 or DBP ≥ 110mmHg) * Renal disorder (Serum creatinine ≥ 2.0mg/dL) * Hepatic disorder (AST or ALT ≥ 2.5 X UNL) * Creatinine Kinase \> 2.5 X UNL * Gravida or lactation phase * Administration of Atorvastatin, Rosuvastatin, Pitavastatin